Effects of Glutamine on Gastric Emptying of Low- and High-Nutrient Drinks in Healthy Young Subjects—Impact on Glycaemia

Glutamine is a potent stimulus for the release of glucagon-like peptide-1, which increases postprandial insulin and slows gastric emptying (GE). We determined the effects of glutamine on GE of, and glycaemic responses to, low- and high-nutrient drinks in eight healthy males (mean age 21.6 ± 0.7 years and BMI 22.9 ± 0.7 kg/m2). Participants were studied on four occasions on which they consumed either a low-nutrient (beef soup; 18 kcal) or high-nutrient (75 g dextrose; 255 kcal) drink, each with or without 30 g of glutamine (120 kcal), in a randomised, crossover design. GE (2D ultrasound), blood glucose and plasma insulin concentrations were measured concurrently. Glutamine slowed GE (half emptying time (T50)) of both low- (45 ± 3 min vs. 26 ± 2 min, p < 0.001), and high-nutrient, (100 ± 5 min vs. 77 ± 5 min, p = 0.03) drinks, however, there was no effect on GE of the high nutrient drinks when expressed as kcal/min (3.39 ± 0.21 kcal/min vs. 3.81 ± 0.20 kcal/min, p = 0.25). There was no change in blood glucose after the low-nutrient drinks with or without glutamine, despite a slight increase in plasma insulin with glutamine (p = 0.007). The rise in blood glucose following the high-nutrient drink (p = 0.0001) was attenuated during the first 60 min by glutamine (p = 0.007). We conclude that in healthy subjects, glutamine slows GE of both low- and high-nutrient drinks comparably and attenuates the rise in blood glucose after the high-nutrient glucose drink.

[1]  J. Wishart,et al.  Relationships of the early insulin secretory response and oral disposition index with gastric emptying in subjects with normal glucose tolerance , 2017, Physiological reports.

[2]  J. Holst,et al.  Glycemic Effects and Safety of L-Glutamine Supplementation with or without Sitagliptin in Type 2 Diabetes Patients—A Randomized Study , 2014, PloS one.

[3]  M. Horowitz,et al.  Relationships Between Gastric Emptying, Postprandial Glycemia, and Incretin Hormones , 2013, Diabetes Care.

[4]  M. Horowitz,et al.  Effects of Intraduodenal Glutamine on Incretin Hormone and Insulin Release, the Glycemic Response to an Intraduodenal Glucose Infusion, and Antropyloroduodenal Motility in Health and Type 2 Diabetes , 2013, Diabetes Care.

[5]  J. Holst,et al.  Glutamine reduces postprandial glycemia and augments the glucagon-like peptide-1 response in type 2 diabetes patients. , 2011, The Journal of nutrition.

[6]  Á. Robles,et al.  The effect of l-alanyl-l-glutamine dipeptide supplemented total parenteral nutrition on infectious morbidity and insulin sensitivity in critically ill patients* , 2011, Critical care medicine.

[7]  D. Lobo,et al.  A randomized crossover study of the effects of glutamine and lipid on the gastric emptying time of a preoperative carbohydrate drink. , 2011, Clinical nutrition.

[8]  M. Teixeira,et al.  The safety of oral use of L-glutamine in middle-aged and elderly individuals. , 2010, Nutrition.

[9]  W. Uhl,et al.  Selective amino acid deficiency in patients with impaired glucose tolerance and type 2 diabetes , 2010, Regulatory Peptides.

[10]  L. Marciani,et al.  Gastric emptying of three liquid oral preoperative metabolic preconditioning regimens measured by magnetic resonance imaging in healthy adult volunteers: a randomised double-blind, crossover study. , 2009, Clinical nutrition.

[11]  V. Vuksan,et al.  Fiber facts: Benefits and recommendations for individuals with type 2 diabetes , 2009, Current diabetes reports.

[12]  R. Campbell,et al.  Type 2 diabetes: where we are today: an overview of disease burden, current treatments, and treatment strategies. , 2009, Journal of the American Pharmacists Association : JAPhA.

[13]  B. Ginsberg Factors Affecting Blood Glucose Monitoring: Sources of Errors in Measurement , 2009, Journal of diabetes science and technology.

[14]  J. Holst The physiology of glucagon-like peptide 1. , 2007, Physiological reviews.

[15]  A. Forbes,et al.  Review article: glucagon‐like peptide 2 – current applications and future directions , 2007, Alimentary pharmacology & therapeutics.

[16]  T. Hausken,et al.  Measurements of gastric emptying of low‐ and high‐nutrient liquids using 3D ultrasonography and scintigraphy in healthy subjects , 2006, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[17]  K. Wynne,et al.  The role of oxyntomodulin and peptide tyrosine–tyrosine (PYY) in appetite control , 2006, Nature Clinical Practice Endocrinology &Metabolism.

[18]  T. Hausken,et al.  Effects of Posture on Gastric Emptying, Transpyloric Flow, and Hunger After a Glucose Drink in Healthy Humans , 2006, Digestive Diseases and Sciences.

[19]  Reawika Chaikomin,et al.  Effects of fat on gastric emptying of and the glycemic, insulin, and incretin responses to a carbohydrate meal in type 2 diabetes. , 2006, The Journal of clinical endocrinology and metabolism.

[20]  P. Flakoll,et al.  Glutamine supplementation increases postprandial energy expenditure and fat oxidation in humans. , 2006, JPEN. Journal of parenteral and enteral nutrition.

[21]  D. Drucker The biology of incretin hormones. , 2006, Cell metabolism.

[22]  J. Holst,et al.  Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects. , 2005, Diabetes.

[23]  G. Rutter,et al.  Glutamine potently stimulates glucagon-like peptide-1 secretion from GLUTag cells , 2004, Diabetologia.

[24]  M. Camilleri,et al.  Assessment of gastric accommodation: overview and evaluation of current methods , 2004, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[25]  Dennis D. Kim,et al.  Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes. , 2003, The Journal of clinical endocrinology and metabolism.

[26]  Claude Colette,et al.  Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). , 2003, Diabetes care.

[27]  Rachel L. Batterham,et al.  Gut hormone PYY3-36 physiologically inhibits food intake , 2002, Nature.

[28]  A. Zinsmeister,et al.  Effects of pramlintide, an amylin analogue, on gastric emptying in type 1 and 2 diabetes mellitus , 2002, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[29]  M. Horowitz,et al.  Gastric emptying in diabetes: clinical significance and treatment , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[30]  R. Ratner Controlling postprandial hyperglycemia. , 2001, The American journal of cardiology.

[31]  M. Nauck Is glucagon-like peptide 1 an incretin hormone? , 1999, Diabetologia.

[32]  P. Flakoll,et al.  Parenteral glutamine infusion alters insulin-mediated glucose metabolism. , 1998, JPEN. Journal of parenteral and enteral nutrition.

[33]  J. Holst,et al.  Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. , 1997, American journal of physiology. Endocrinology and metabolism.

[34]  J. Wishart,et al.  Gastric emptying in early noninsulin-dependent diabetes mellitus. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[35]  K. Hveem,et al.  Scintigraphic measurement of gastric emptying and ultrasonographic assessment of antral area: relation to appetite. , 1996, Gut.

[36]  J. Wishart,et al.  The effect of short-term dietary supplementation with glucose on gastric emptying of glucose and fructose and oral glucose tolerance in normal subjects , 1996, Diabetologia.

[37]  J. Dent,et al.  Role and integration of mechanisms controlling gastric emptying , 1994, Digestive Diseases and Sciences.

[38]  J. Wishart,et al.  Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects , 1993, Diabetologia.

[39]  H. Grill,et al.  Dynamics of gastric emptying during and after stomach fill. , 1992, The American journal of physiology.

[40]  J. Dent,et al.  Disordered gastric emptying: mechanical basis, assessment and treatment. , 1991, Bailliere's clinical gastroenterology.

[41]  J. Meyer,et al.  Inhibition of gastric emptying by glucose depends on length of intestine exposed to nutrient. , 1989, The American journal of physiology.

[42]  P. McHugh,et al.  Regulation of the gastric emptying of glucose. , 1983, Gastroenterology.

[43]  Karen L Jones,et al.  Endogenous glucagon-like peptide-1 slows gastric emptying in healthy subjects, attenuating postprandial glycemia. , 2010, The Journal of clinical endocrinology and metabolism.

[44]  J. Holst,et al.  Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and type 2 diabetic subjects. , 2009, The American journal of clinical nutrition.

[45]  M. Henderson,et al.  Oral glutamine in paediatric oncology patients: a dose finding study , 2003, European Journal of Clinical Nutrition.

[46]  E. Feskens,et al.  Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. , 2001, Archives of internal medicine.